An exciting regulatory update 🙌 | Sempresto
https://wefunder.com/feed/389530
Published at: 2026-09-17 20:19:17 UTC
Subject: Sempresto
Sempresto reached an important regulatory milestone this month: we received written feedback from the FDA following our Type B pre-IND meeting.